February 3, 2016 National News Release
25,000 awarded to youth pursuing a post-secondary education in areas of science, technology, engineering or math
February 3, 2016 Toronto The Multiple Sclerosis Society of Canada is proud to announce the John Helou Scholarship made possible through the generous support of Pfizer and Innovative Medicines Canada an innovative approach to supporting young Canadians who are affected by multiple sclerosis. Named for John Helou, Immediate Past Chair, Innovative Medicines Canada and President, Pfizer Canada Inc., the scholarshipwill award up to two exceptional youth who plan to complete a post-secondary degree in the areas of science, technology, engineering or math (STEM) academic streams that directly influence ongoing work to end MS.
We are pleased to offer the John Helou Scholarship to empower youth with the financial support they need to overcome the financial obstacles that often accompany a personal or familial diagnosis of MS, says Sylvia Leonard, National Vice President, Programs & Services, MS Society of Canada. This opportunity will enable high-achieving young Canadians to reach their full potential and become a part of the next generation of MS leaders.
All eligible candidates are required to submit a completed scholarship application form no later than March 31, 2016, 11:59pm ET. Recipients must be enrolled in a science, technology, engineering or math undergraduate program for the 2016/17 academic year and will receive $6,250 per year for four years to apply to tuition for a total scholarship of $25,000.
For more information about the John Helou Scholarship, including eligibility criteria, and other scholarship opportunities available from the MS Society of Canada, the public may visit mssociety.ca/scholarships.
https://mssociety.ca/news/article/ms...tiple-sclerosi
https://juno.aucc.ca/wes/dev/guideli...?pgm=344&lg=en
25,000 awarded to youth pursuing a post-secondary education in areas of science, technology, engineering or math
February 3, 2016 Toronto The Multiple Sclerosis Society of Canada is proud to announce the John Helou Scholarship made possible through the generous support of Pfizer and Innovative Medicines Canada an innovative approach to supporting young Canadians who are affected by multiple sclerosis. Named for John Helou, Immediate Past Chair, Innovative Medicines Canada and President, Pfizer Canada Inc., the scholarshipwill award up to two exceptional youth who plan to complete a post-secondary degree in the areas of science, technology, engineering or math (STEM) academic streams that directly influence ongoing work to end MS.
We are pleased to offer the John Helou Scholarship to empower youth with the financial support they need to overcome the financial obstacles that often accompany a personal or familial diagnosis of MS, says Sylvia Leonard, National Vice President, Programs & Services, MS Society of Canada. This opportunity will enable high-achieving young Canadians to reach their full potential and become a part of the next generation of MS leaders.
All eligible candidates are required to submit a completed scholarship application form no later than March 31, 2016, 11:59pm ET. Recipients must be enrolled in a science, technology, engineering or math undergraduate program for the 2016/17 academic year and will receive $6,250 per year for four years to apply to tuition for a total scholarship of $25,000.
For more information about the John Helou Scholarship, including eligibility criteria, and other scholarship opportunities available from the MS Society of Canada, the public may visit mssociety.ca/scholarships.
https://mssociety.ca/news/article/ms...tiple-sclerosi
https://juno.aucc.ca/wes/dev/guideli...?pgm=344&lg=en
Comment